Acetyl-l-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury

Journal of Neurochemistry

Volumn 114, Issue 1, 2010, Pages 291-301

  Patel, Samir P ^a   Sullivan, Patrick G ^a   Lyttle, Travis S ^a   Rabchevsky, Alexander G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cytochrome c oxidase; Mitochondrial bioenergetics; NADH dehydrogenase; Neuroprotection; Pyruvate dehydrogenase

Indexed keywords

CYTOCHROME C OXIDASE; LEVACECARNINE; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONTUSION; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; GRAY MATTER; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; THORACIC SPINAL CORD;

ACETYLCARNITINE; ANIMALS; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; FEMALE; MITOCHONDRIA; NADH DEHYDROGENASE; NEUROPROTECTIVE AGENTS; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

RATTUS;

EID: 77953294755     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06764.x     Document Type: Article

References (69)

1. Alves E., Binienda Z., Carvalho F., Alves C. J., Fernandes E., de Lourdes Bastos M., Tavares M. A. Summavielle T. (2009) Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain. Neuroscience 158, 514 523.
2. Anonymous (1999) Acetyl-L-carnitine. Altern. Med. Rev. 4, 438 441.
3. Aureli T., Puccetti C., Di Cocco M. E., Arduini A., Ricciolini R., Scalibastri M., Manetti C. Conti F. (1999) Entry of [(1,2-13C2)acetyl]-L- carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats. Eur. J. Biochem. 263, 287 293.
4. Barnes C. A., Markowska A. L., Ingram D. K., Kametani H., Spangler E. L., Lemken V. J. Olton D. S. (1990) Acetyl-1-carnitine. 2: effects on learning and memory performance of aged rats in simple and complex mazes. Neurobiol. Aging 11, 499 506.
5. Bogaert Y. E., Sheu K. F., Hof P. R., Brown A. M., Blass J. P., Rosenthal R. E. Fiskum G. (2000) Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp. Neurol. 161, 115 126.
6. Bonavita E. (1986) Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int. J. Clin. Pharmacol. Ther. Toxicol. 24, 511 516.
7. Bracken M. B., Shepard M. J., Holford T. R. et al. (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. J. Am. Med. Assoc. 277, 1597 1604.
8. Calabrese V., Ravagna A., Colombrita C., Scapagnini G., Guagliano E., Calvani M., Butterfield D. A. Giuffrida Stella A. M. (2005) Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J. Neurosci. Res. 79, 509 521.
9. Carta A. Calvani M. (1991) Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease? Ann. N Y Acad. Sci. 640, 228 232.
10. Chiechio S., Caricasole A., Barletta E. et al. (2002) L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol. Pharmacol. 61, 989 996.
11. Clark J. B. Nicklas W. J. (1970) The metabolism of rat brain mitochondria. Preparation and characterization. J. Biol. Chem. 245, 4724 4731.
12. De Meirleir L., Lissens W., Denis R., Wayenberg J. L., Michotte A., Brucher J. M., Vamos E., Gerlo E. Liebaers I. (1993) Pyruvate dehydrogenase deficiency: clinical and biochemical diagnosis. Pediatr. Neurol. 9, 216 220. (Pubitemid 23199470)
13. Dhitavat S., Ortiz D., Shea T. B. Rivera E. R. (2002) Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem. Res. 27, 501 505.
14. Di Cesare Mannelli L., Ghelardini C., Calvani M., Nicolai R., Mosconi L., Vivoli E., Pacini A. Bartolini A. (2007) Protective effect of acetyl-L-carnitine on the apoptotic pathway of peripheral neuropathy. Eur. J. Neurosci. 26, 820 827.
15. Di Cesare Mannelli L., Ghelardini C., Calvani M., Nicolai R., Mosconi L., Toscano A., Pacini A. Bartolini A. (2009) Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor. J. Neurosci. Res. 87, 200 207.
16. Fiskum G., Rosenthal R. E., Vereczki V., Martin E., Hoffman G. E., Chinopoulos C. Kowaltowski A. (2004) Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J. Bioenerg. Biomembr. 36, 347 352. (Pubitemid 39619839)
17. Ghirardi O., Milano S., Ramacci M. T. Angelucci L. (1989) Long-term acetyl-L-carnitine preserves spatial learning in the senescent rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 13, 237 245.
18. Hall E. D. Springer J. E. (2004) Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1, 80 100.
19. Jin Y., McEwen M. L., Nottingham S. A., Maragos W. F., Dragicevic N. B., Sullivan P. G. Springer J. E. (2004) The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord. J. Neurotrauma 21, 1396 1404.
20. Long J., Gao F., Tong L., Cotman C. W., Ames B. N. Liu J. (2009) Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine. Neurochem. Res. 34, 755 763.
21. Lowitt S., Malone J. I., Salem A. F., Korthals J. Benford S. (1995) Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 44, 677 680.
22. Luo J., Borgens R. Shi R. (2004) Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J. Neurotrauma 21, 994 1007. (Pubitemid 39096850)
23. Markowska A. L., Ingram D. K., Barnes C. A., Spangler E. L., Lemken V. J., Kametani H., Yee W. Olton D. S. (1990) Acetyl-1-carnitine. 1: effects on mortality, pathology and sensory-motor performance in aging rats. Neurobiol. Aging 11, 491 498.
24. Martin E., Rosenthal R. E. Fiskum G. (2005) Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J. Neurosci. Res. 79, 240 247.
25. McDaniel M. A., Maier S. F. Einstein G. O. (2003) "Brain- specific" nutrients: a memory cure? Nutrition 19, 957 975.
26. McEwen M. L., Sullivan P. G. Springer J. E. (2007) Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats. J. Neurotrauma 24, 613 624.
27. Michel R. P. Cruz-Orive L. M. (1988) Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J. Microsc. 150, 117 136.
28. Musicco C., Capelli V., Pesce V., Timperio A. M., Calvani M., Mosconi L., Zolla L., Cantatore P. Gadaleta M. N. (2009) Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria. Biochim. Biophys. Acta 1787, 890 896.
29. Nicklas W. J., Clark J. B. Williamson J. R. (1971) Metabolism of rat brain mitochondria. Studies on the potassium ion-stimulated oxidation of pyruvate. Biochem. J. 123, 83 95.
30. Onofrj M., Fulgente T., Melchionda D. et al. (1995) L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Int. J. Clin. Pharmacol. Res. 15, 9 15.
31. Onose G., Anghelescu A., Muresanu D. F. et al. (2009) A review of published reports on neuroprotection in spinal cord injury. Spinal Cord 47, 716 726.
32. Opii W. O., Nukala V. N., Sultana R., Pandya J. D., Day K. M., Merchant M. L., Klein J. B., Sullivan P. G. Butterfield D. A. (2007) Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J. Neurotrauma 24, 772 789.
33. Paradies G., Petrosillo G., Gadaleta M. N. Ruggiero F. M. (1999) The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett. 454, 207 209.
34. Parnetti L., Gaiti A., Mecocci P., Cadini D. Senin U. (1992) Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type. Eur. J. Clin. Pharmacol. 42, 89 93.
35. Patel S. P., Sullivan P. G., Pandya J. D. Rabchevsky A. G. (2009) Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury. J. Neurosci. Res. 87, 130 140.
36. Petruzzella V., Baggetto L. G., Penin F., Cafagna F., Ruggiero F. M., Cantatore P. Gadaleta M. N. (1992) In vivo effect of acetyl-L-carnitine on succinate oxidation, adenine nucleotide pool and lipid composition of synaptic and non-synaptic mitochondria from cerebral hemispheres of senescent rats. Arch. Gerontol. Geriatr. 14, 131 144.
37. Pettegrew J. W., Levine J. McClure R. J. (2000) Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiatry 5, 616 632.
38. Pocernich C. B. Butterfield D. A. (2003) Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox. Res. 5, 515 520.
39. Puca F. M., Genco S., Specchio L. M. et al. (1990) Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease. Int. J. Clin. Pharmacol. Res. 10, 139 143.
40. Rabchevsky A. G. Smith G. M. (2001) Therapeutic interventions following mammalian spinal cord injury. Arch. Neurol. 58, 721 726.
41. Rabchevsky A. G., Fugaccia I., Sullivan P. G. Scheff S. W. (2001) Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 18, 513 522.
42. Rai G., Wright G., Scott L., Beston B., Rest J. Exton-Smith A. N. (1990) Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia. Curr. Med. Res. Opin. 11, 638 647.
43. Reed L. J. (1981) Regulation of mammalian pyruvate dehydrogenase complex by a phosphorylation-dephosphorylation cycle. Curr. Top. Cell. Regul. 18, 95 106.
44. Reed L. J. (2001) A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. J. Biol. Chem. 276, 38329 38336.
45. Richards E. M., Rosenthal R. E., Kristian T. Fiskum G. (2006) Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activity. Free Radic. Biol. Med. 40, 1960 1970.
46. Robertson C. L., Saraswati M. Fiskum G. (2007) Mitochondrial dysfunction early after traumatic brain injury in immature rats. J. Neurochem. 101, 1248 1257.
47. Rosenthal P. B. Henderson R. (2003) Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721 745.
48. Roy Chowdhury S. K., Sangle G. V., Xie X., Stelmack G. L., Halayko A. J. Shen G. X. (2009) Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am. J. Physiol. Endocrinol. Metab. doi:10.1152/ajpendo.00433.2009.
49. Sano M., Bell K., Cote L. et al. (1992) Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch. Neurol. 49, 1137 1141.
50. Sheu K. F., Kim Y. T., Blass J. P. Weksler M. E. (1985) An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol. 17, 444 449.
51. Sima A. A., Ristic H., Merry A., Kamijo M., Lattimer S. A., Stevens M. J. Greene D. A. (1996) Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J. Clin. Invest. 97, 1900 1907.
52. Smith L. (1955) Spectrophotometric assay of cytochrome c oxidase. Methods Biochem. Anal. 2, 427 434.
53. Sorbi S., Bird E. D. Blass J. P. (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13, 72 78.
54. Spagnoli A., Lucca U., Menasce G. et al. (1991) Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 41, 1726 1732.
55. Starkov A. A., Fiskum G., Chinopoulos C., Lorenzo B. J., Browne S. E., Patel M. S. Beal M. F. (2004) Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 24, 7779 7788.
56. Storey B. T. (1980) Strategy of oxidative metabolism in bull spermatozoa. J. Exp. Zool. 212, 61 67.
57. Stout A. K., Raphael H. M., Kanterewicz B. I., Klann E. Reynolds I. J. (1998) Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1, 366 373.
58. Sullivan P. G., Dube C., Dorenbos K., Steward O. Baram T. Z. (2003) Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann. Neurol. 53, 711 717.
59. Sullivan P. G., Rabchevsky A. G., Waldmeier P. C. Springer J. E. (2005) Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci. Res. 79, 231 239.
60. Sullivan P. G., Krishnamurthy S., Patel S. P., Pandya J. D. Rabchevsky A. G. (2007) Temporal characterization of mitochondrial bioenergetics after spinal cord injury. J. Neurotrauma 24, 991 999.
61. Swamy-Mruthinti S. Carter A. L. (1999) Acetyl- L -carnitine decreases glycation of lens proteins: in vitro studies. Exp. Eye Res. 69, 109 115.
62. Tempesta E., Casella L., Pirrongelli C., Janiri L., Calvani M. Ancona L. (1987) L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo. Drugs Exp. Clin. Res. 13, 417 423.
63. Tomassini V., Pozzilli C., Onesti E., Pasqualetti P., Marinelli F., Pisani A. Fieschi C. (2004) Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J. Neurol. Sci. 218, 103 108.
64. Traina G., Bernardi R., Rizzo M., Calvani M., Durante M. Brunelli M. (2006) Acetyl-L-carnitine up-regulates expression of voltage-dependent anion channel in the rat brain. Neurochem. Int. 48, 673 678.
65. Vazquez-Memije M. E., Capin R., Tolosa A. El-Hafidi M. (2008) Analysis of age-associated changes in mitochondrial free radical generation by rat testis. Mol. Cell. Biochem. 307, 23 30.
66. Virmani A. Binienda Z. (2004) Role of carnitine esters in brain neuropathology. Mol. Aspects Med. 25, 533 549.
67. Wei Y. H., Wu S. B., Ma Y. S. Lee H. C. (2009) Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med. J. 32, 113 132.
68. Zaidan E., Sheu K. F. Sims N. R. (1998) The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. J. Neurochem. 70, 233 241.
69. Zhang H., Jia H., Liu J., Ao N., Yan B., Shen W., Wang X., Li X. Luo C. (2010) Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease. J. Cell Mol. Med. 14, 215 225.